Canterra Minerals Corporation (TSXV:CTM)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.59	4.89	1.82	0.65	3.06	3.85
Short-Term Investments	1.05	0.44	0	0	0	0
Cash & Short-Term Investments	4.64	5.33	1.82	0.65	3.06	3.85
Cash Growth	314.05%	192.47%	178.60%	-78.64%	-20.62%	34977.00%
Other Receivables	0.12	0.13	0.02	0.03	0.21	0.01
Receivables	0.12	0.13	0.02	0.03	0.21	0.01
Prepaid Expenses	0.07	0.02	0.06	-	0.04	0.02
Total Current Assets	4.83	5.48	1.9	0.69	3.31	3.88
Property, Plant & Equipment	15.58	15.55	15.96	4.42	4.33	2.23
Other Long-Term Assets	0	0	0	0	0	0
Total Assets	20.41	21.03	17.86	5.11	7.65	6.11
Accounts Payable	0.28	0.11	0.18	0.87	0.24	0.3
Accrued Expenses	0.33	0.21	0.1	0.03	0.03	0.03
Current Unearned Revenue	0.49	0.69	-	-	0.11	-
Total Current Liabilities	1.1	1.01	0.28	0.9	0.38	0.33
Total Liabilities	1.1	1.01	0.28	0.9	0.38	0.33
Common Stock	134.56	134.56	120.17	116.27	115.84	111.57
Retained Earnings	-118.15	-117.41	-114.28	-114.55	-111.51	-106.78
Comprehensive Income & Other	2.9	2.88	11.7	2.5	2.93	0.99
Shareholders' Equity	19.3	20.02	17.58	4.21	7.27	5.78
Total Liabilities & Equity	20.41	21.03	17.86	5.11	7.65	6.11
Net Cash (Debt)	4.64	5.33	1.82	0.65	3.06	3.85
Net Cash Growth	314.05%	192.47%	178.60%	-78.64%	-20.62%	-
Net Cash Per Share	0.02	0.03	0.02	0.01	0.05	0.36
Filing Date Shares Outstanding	343.32	343.32	148.82	100.13	77.05	52.66
Total Common Shares Outstanding	343.32	343.32	148.82	77.05	76.8	52.66
Working Capital	3.73	4.46	1.62	-0.21	2.93	3.55
Book Value Per Share	0.06	0.06	0.12	0.05	0.09	0.11
Tangible Book Value	19.3	20.02	17.58	4.21	7.27	5.78
Tangible Book Value Per Share	0.06	0.06	0.12	0.05	0.09	0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.